Related Experiment Videos
Synovial sarcoma. A DNA flow cytometric study.
A K el-Naggar1, A G Ayala, F W Abdul-Karim
1Department of Pathology, University of Texas M. D. Anderson Cancer Center, Houston 77030.
Cancer
|May 15, 1990
Summary
Patient age, tumor size, and DNA ploidy status significantly impact synovial sarcoma survival. DNA ploidy analysis offers a valuable tool for predicting patient outcomes in this cancer.
Area of Science:
- Oncology
- Pathology
- Molecular Biology
Background:
- Synovial sarcoma is a rare soft tissue sarcoma.
- Understanding prognostic factors is crucial for patient management.
Purpose of the Study:
- To investigate the correlation between DNA content, clinicopathologic factors, and survival in synovial sarcoma.
- To identify objective markers for prognostication.
Main Methods:
- Retrospective analysis of patient data.
- Evaluation of DNA content, ploidy status, and S-phase fraction using flow cytometry.
- Correlation with clinicopathologic findings and patient survival.
Main Results:
- Patient age, tumor size, and DNA ploidy status showed significant correlation with survival (P < 0.001, P < 0.001, P < 0.003 respectively).
- Mitotic count showed a marginally significant correlation with survival (P = 0.04).
- Histologic subtypes and S-phase fraction did not significantly influence clinical outcome.
Conclusions:
- DNA ploidy analysis is a significant objective marker for prognostication in synovial sarcoma.
- Age and tumor size are also important prognostic indicators.